arrow
S

Stephen Parker

The University of Queensland
H指数:25
被引数:2,725

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Commentary on the ANZJP Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia – Where are the recommendations for methamphetamine-related psychoses?

对《ANZJP关于精神分裂症管理的GRADE指南》的评论——关于甲基苯丙胺相关精神病的建议在哪里?

2026-09-090
PRE
An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study

一项运动生理学家服务以提高严重精神疾病成人生活质量的有效性试验:MOVEMENT研究的方案

2025-07-110
OA
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

司美格鲁肽相对于安慰剂在服用氯氮平并伴有肥胖的精神分裂症患者中的疗效与安全性(COaST):一项在澳大利亚进行的第2阶段、多中心、参与者与研究者双盲、随机对照试验

2025-06-100
PRE
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia

Cancloz方案: 大麻二酚治疗氯氮平耐药精神分裂症的多中心随机,安慰剂对照,双盲,平行组适应性试验

2024-10-030
OAAI
Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST)

司马鲁肽对氯氮平治疗的精神分裂症和肥胖症患者体重的影响: 安慰剂对照,随机多中心试验 (COaST) 的研究方案

2023-07-256
OAAI